ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MPOW Mopowered Grp

3.75
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mopowered Grp LSE:MPOW London Ordinary Share GB00BGDW0L56 ORD 0.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.75 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Mopowered Grp Share Discussion Threads

Showing 251 to 273 of 375 messages
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
23/9/2014
11:43
No still watching for the bottom, as for AMI wonder if you are still smiling next Tuesday when results are released
sweepie2
23/9/2014
11:41
Well, they have now comprehensively beaten Outsourcery to the prize of "Turkey float of the last year" congratulations!
salpara111
23/9/2014
11:06
Anyone care to guess what Singer's got paid to do the placing?
papillon88
23/9/2014
10:44
yeh it seems more like par for the course for aim cesspit stocks
the stigologist
23/9/2014
10:39
You will be surprised to know Tpet has a placing @ -85%. LOL


malhashemi 23 Sep'14 - 10:15 - 254 of 257 0 0

Never seen or heard of a placing at 75% discount my entire life.. This one is for the record books

bad robot
23/9/2014
10:38
ignorant or liar ?


TOPINFO
23 Sep'14 - 10:35 - 444885 of 444885 0 0

If your share price is 24p and you go with the begging bowl to the city and ask for funding and you get it offered but at 5p, what does that say about your business and the confidence in it going forward. Never seen such a discounted placing in all my years doing this tbh.

the stigologist
23/9/2014
10:20
In order to recapitalise the Company, Peterhouse has conditionally raised £300,000 at 0.06 pence per Subscription Share, through the subscription of 500,000,000 new Ordinary Shares representing 53.7% of the issued ordinary share capital. The members of the Consortium have each agreed to sell their entire holdings in SSM (being 203,536,656 Ordinary Shares in aggregate, representing 47.2 per cent. of the existing issued ordinary share capital) to the investors, on a pro rata basis to their investment, for a nominal sum of £1, the effect of which is to reduce the price per share being paid by the Investors to 0.04 pence per share.
the stigologist
23/9/2014
10:18
look at SPSM

had placing at 96% discount i think

the stigologist
23/9/2014
10:15
Never seen or heard of a placing at 75% discount my entire life.. This one is for the record books
malhashemi
22/9/2014
14:47
I certainly know that I will be making a mental note of the board members involved in this company and never investing in future companies they are involved in.
bigdazzler
22/9/2014
13:43
Me and Sheila are gonna pay no more then 1.75p
Sensible comments appreciated

sanks
22/9/2014
13:04
Punters just cannot wait to line mm and broker pockets. Paying 7p and 8p when
placing at 5p you should be paying no more than 6p for them which is still 20%
to them.

21trader
22/9/2014
12:06
A hopeless prospect here imo. If their products were any good or their management not useless, there is no way 5p would have been a placing price. The heaviest discount I think I have ever seen.

Without any exaggeration I would expect this to move below 5p.

loverat
22/9/2014
11:54
Can't ever see an entry point for investing in MPOW anymore.
70m new shares on top of the existing 16m.
As long as the share price is above 5p, the new placees will just drip-sell to any new buyers.
Way before the market has worked through such a massive chunk, the company will have eaten its way through the new cash, unless revenue soars.
It is, therefore, a clear bet on the company ramping up revenue in a dramatic way.
Does revenue at tech companies just start soaring from one day to the next? Not according to the Technology Adoption Life Cycle theory.
Obviously a very poorly-managed company. Only recently IPO'ed and ate through the money raised on admission at a rate of knots. With the cost structure they have (and giving them the benefit of the doubt that all the money is being poured into development and commercialisation of the products), they have clearly underestimated the market opportunity for their products, otherwise they should clearly have raised far more money like eg Wandisco (although that company is also ravenous for cash on a greater scale).

bakunin
22/9/2014
11:50
Ticking up now....7.65p paid for miniscule at 1147hrs.

m

fillipe
22/9/2014
11:27
The guy BR is a pumper and a dumper...beware of it!

Snakes have better chracter!!!

makday
22/9/2014
11:08
I am not touching this before 2p.

Anyway check out cza. DYOR

currently top riser

bad robot
22/9/2014
10:59
Still watching haven't bought yet as accepting 5p does make them pretty desperate so does make you think what else is rotten in their larder.
But for reasons stated above I am interested

sweepie2
22/9/2014
10:24
cza is kicking off
bad robot
22/9/2014
10:11
where's sweetpie?
bad robot
22/9/2014
09:46
might be worth putting the money in BMK

BMK: The vaccine jab for kitty that could cure your allergy to cats:


Millions of cat allergy sufferers know the symptoms only too well – red, itchy eyes, uncontrollable sneezes, coughing fits, even a nasty rash.
But help could soon be at hand thanks to a British company working on a vaccine it says can render even the fluffiest feline totally harmless.
Sheffield-based Benchmark says its revolutionary injection can ‘neutralise’ the cat itself, rather than forcing humans to resort to costly treatments that often have limited effect.
A British company is working on a vaccine which it says can render even the fluffiest feline totally harmless to allergy sufferers
+2
A British company is working on a vaccine which it says can render even the fluffiest feline totally harmless to allergy sufferers
It works by attacking a protein carried in cats’ saliva, urine and sweat that is the most common cause of cat allergies.
More than 725m people, about a tenth of the global population, are thought to be allergic to cats but options for alleviating the symptoms are limited.



Sufferers can take anti-histamines or have regular injections designed to stimulate the body’s natural immune system.
Some websites recommend using air purifiers or even bathing your cat as often as possible, which can prove difficult if the animal doesn’t cooperate.
The new vaccine, dubbed HypoCat, works by attacking the Fel d 1 protein, the main allergen carried by cats and kittens.
Fel d 1, present in saliva, urine and sweat, is spread all over the cat’s fur when it licks itself clean.
Pugh Allergy Job.jpg
+2
The protein then attaches itself to cat dander, tiny particles of dry skin one tenth the size of a dust mite.
As cats prowl their territory, they leave dander on surfaces such as bedding and sofas, wreaking havoc on allergy sufferers whose symptoms are triggered by the protein.
But Benchmark claims that HypoCat can ‘neutralise’ the Fel d 1 protein altogether, without harming the cat.
It is spending up to £8million to commercialise research by Swiss firm HypoPet, based at the University of Zurich, in the hope of making HypoCat available through vets within three or four years.
Maureen Jenkins, clinical director of Allergy UK, said the vaccine could make a huge difference to allergy suffereds in the UK, which hosts an army of around 8.5million cats.
‘It’s a major problem in this country so this could be very significant,’ she said.
‘Some people avoid cats like the plague and when they are then exposed they could have a very serious reaction.’
‘It’s also something that can cause chronic ongoing systems and a lot of people don’t realise what the cause is.’
Benchmark said it believes that HypoCat could open up a new market for cat vaccinations worth as much as £250million.
Life sciences analysts at City of London firm Cenkos Securities said: ‘There is a large potential market for this vaccine.’
‘We believe that this approach will lead to a relatively straightforward solution for cat owners and the population that suffers from cat allergies,’ they added.



Read more:

opodio
22/9/2014
09:42
I may buy some at 2p for the dead cat bounce to 4p
bad robot
22/9/2014
09:42
LOL

That's what your mates said on ami from 160p to 16p

bad robot
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock